I’m clearly not a fan of CANN or it’s management - but they wouldn’t pay for a clinical trial they didn’t think would be successful.
It’s a huge blow obviously. The reaction to the initial external interest in their study/product suggested many believed it was a formality.
There’s a few threads on here where people were calling it a sure thing and anyone that commented otherwise were labelled as downrampers or as having an agenda… and I really wish those people would admit they are wrong.
- Forums
- ASX - By Stock
- Ann: S3 Trial update
I’m clearly not a fan of CANN or it’s management - but they...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAN (ASX) Chart |
Day chart unavailable
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online